Ye Muyao, Wang Chang, Li Ling, Zhao Qiulan, Peng Youming, Liu Hong
Department of Nephrology, The Second Xiangya Hospital/Central South University, No. 139 Renmin Middle Rd, Changsha, 410011, Hunan, China.
Immunol Res. 2022 Feb;70(1):86-96. doi: 10.1007/s12026-021-09223-2. Epub 2021 Oct 12.
While β-hemolytic streptococcus (β-HS) infections are known to predispose patients to acute poststreptococcal glomerulonephritis, there is evidence that implicates α-hemolytic streptococcus (α-HS) in IgA nephropathy (IgAN). The alternative pathway of the complement system has also been implicated in IgAN. We aimed to explore the association between α-HS and complement activation in human tonsillar mononuclear cells (TMCs) in IgAN. In our study, α-HS induced higher IgA levels than IgG levels, while β-HS increased higher IgG levels than IgA levels with more activation-induced cytidine deaminase, in TMCs in the IgAN group. Aberrant IgA1 O-glycosylation levels were higher in IgAN patients with α-HS. C3 and C3b expression was decreased in IgAN patients, but in chronic tonsillitis control patients, the expression decreased only after stimulation with β-HS. Complement factor B and H (CFH) mRNA increased, but the CFH concentration in culture supernatants decreased with α-HS. The percentage of CD19 + CD35 + cells/complement receptor 1 (CR1) decreased with α-HS more than with β-HS, while CD19 + CD21 + cells/complement receptor 2 (CR2) increased more with β-HS than with α-HS. The component nephritis-associated plasmin receptor (NAPlr) of α-HS was not detected on tonsillar or kidney tissues in IgAN patients and was positive on cultured TMCs and mesangial cells. We concluded that α-HS induced the secretion of aberrantly O-glycosylated IgA while decreasing the levels of the inhibitory factor CFH in culture supernatants and CR1 + B cells. These findings provide testable mechanisms that relate α-HS infection to abnormal mucosal responses involving the alternative complement pathway in IgAN.
虽然已知β溶血性链球菌(β-HS)感染会使患者易患急性链球菌感染后肾小球肾炎,但有证据表明α溶血性链球菌(α-HS)与IgA肾病(IgAN)有关。补体系统的替代途径也与IgAN有关。我们旨在探讨α-HS与IgAN患者扁桃体单个核细胞(TMCs)中补体激活之间的关联。在我们的研究中,在IgAN组的TMCs中,α-HS诱导的IgA水平高于IgG水平,而β-HS诱导的IgG水平高于IgA水平,且激活诱导的胞苷脱氨酶更多。α-HS阳性的IgAN患者异常IgA1 O-糖基化水平更高。IgAN患者中C3和C3b表达降低,但在慢性扁桃体炎对照患者中,仅在β-HS刺激后表达才降低。补体因子B和H(CFH)mRNA增加,但α-HS刺激后培养上清液中的CFH浓度降低。α-HS刺激后,CD19 + CD35 +细胞/补体受体1(CR1)的百分比下降幅度大于β-HS刺激后,而β-HS刺激后CD19 + CD21 +细胞/补体受体2(CR2)的增加幅度大于α-HS刺激后。在IgAN患者的扁桃体或肾脏组织中未检测到α-HS的肾炎相关纤溶酶受体(NAPlr)成分,但在培养的TMCs和系膜细胞中呈阳性。我们得出结论,α-HS诱导异常O-糖基化IgA的分泌,同时降低培养上清液中抑制因子CFH和CR1 + B细胞的水平。这些发现提供了可验证的机制,将α-HS感染与IgAN中涉及替代补体途径的异常黏膜反应联系起来。